| Adverse event | Grade 0 | Grade 1 | Grade 2 | Grade 3 | Grade 4 |
| Blood | |||||
| Anaemia | 0 | 1 (12.5%) | 3 (37.5%) | 4 (50%) | 0 |
| Leucocytopenia | 1 (12.5%) | 0 | 2 (25%) | 4 (50%) | 1 (12.5%) |
| Thrombocytopenia | 1(12.5%) | 1 (12.5%) | 0 | 2 (25%) | 4 (50%) |
| Nervoussystem | |||||
| Polyneuropathy | 0 | 2 (25%) | 1 (12.5%) | 0 | 0 |
| Further adverse events | |||||
| Hypertension | 0 | 0 | 0 | 3 (37.5%) | 0 |
| Allergy | 0 | 0 | 0 | 1 (12.5%) | 0 |
| Emesis | 0 | 0 | 4 (50%) | 4 (50%) | 0 |
| Acute renal failure | 0 | 0 | 0 | 1 (12.5%) | 0 |
| Bleeding (tissue) | 0 | 0 | 0 | 0 | 1 (12.5%) |
| Bleeding (Epistaxis) | 0 | 3 (37.5%) | 0 | 0 | 0 |
| Infection (Pneumonia, Urosepsis, Fungalsepsis) | 0 | 0 | 0 | 3 (37.5%) | 0 |